An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension
Clinical trial NCT02882126 · WITHDRAWN
Trial details
- NCT number
- NCT02882126
- Sponsor
- United Therapeutics
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.